Germany points way to solve UK’s clinical research gap
Germany could provide some answers to a major challenge facing the United Kingdom’s National Health Service (NHS) – that of translating scientific discoveries into life-saving treatments and improving health outcomes by encouraging more young early-career doctors to become clinical academics.
The United Kingdom is facing a growing problem with a fall in recruiting and retaining younger physicians and academics specialising in medicine into clinical scientist roles, which combine frontline patient-facing practice with advanced biomedical research.
Despite their critical role, the clinical academic workforce has not kept pace with NHS expansion.
Not just a British problem
And the challenge is not just a British problem, with Germany perhaps providing some of the answers with their pioneering structured Stiftung Charité clinician scientist training programme, which addresses one of the major barriers facing young physicians: the lack of protected time for research alongside their clinical responsibilities.
Alarm bells have been ringing more loudly in the UK, highlighted in a 2025 clinical academic survey by the Medical Schools Council, which revealed that the number of clinical academics in medicine aged under 36 fell by a quarter between 2024 and 2025 (dropping from 140 to 105 full-time equivalent positions).
The Royal College of Physicians (RCP) has warned that the pipeline of early-career clinical academics is now outnumbered by those nearing retirement, raising concerns about the future capacity of the research and innovation workforce as practising clinical scientists continue to age.
The RCP is among those calling for urgent action to safeguard clinical academic careers and warns that the British government’s ambitions to expand patient access to clinical trials will be at risk unless the doctors who design and deliver the research are better supported.
Russell Group commitments
That’s why a series of new commitments from the Russell Group of leading UK research-intensive universities to help attract, develop and retain clinical academics has been warmly welcomed by the medical research and education community.
The Russell Group (RG) has 24 member institutions, 22 of which have medical schools, and 70% of the training of new doctors in the UK is undertaken by its member universities in partnership with NHS hospitals and primary care settings.
The new RG commitments follow their own findings last year, published in a report called Securing the Future of Clinical Research, which said the shrinking of the early-career clinical academic pool was due to structural and financial barriers that threaten delivery of the NHS 10 Year Health Plan, the Life Sciences Sector Plan and regional ambitions for health-driven economic growth.
Structural and financial barriers
“These barriers include unclear and inflexible career pathways, insufficient institutional support and misaligned expectations between universities and the NHS,” according to the Russell Group, which announced on 12 November 2026 that its 24 universities have collectively committed to taking action to strengthen clinical academic careers across medicine, nursing, midwifery, allied health professions and the wider health and social care workforce.
Working with the NHS, research funders and other partners, the Russell Group has pledged to:
• Build better and earlier awareness of this rewarding career path, with outreach activities in schools, colleges and local communities to help young people and the wider public understand the exciting career opportunities available.
• Support lifelong career development, enabling people to enter, return to and progress as clinical academics at different stages of their career.
• Demonstrate more clearly to patients, healthcare workers and research funders the value clinical academics bring to our health and care services.
• Forge stronger partnerships across health, research and innovation to support better patient outcomes as well as regional growth.
Libby Hackett, the Russell Group’s chief executive, said: “Clinical academics are the bridge between world-class medical research and the care patients receive every day. But we risk losing vital talent at precisely the point when the UK needs it most.
“These commitments are about going further, including by raising awareness of the value of these roles and career opportunities so more talented people take the chance to combine research and patient care for an exciting, rewarding career journey.”
She said that the Russell Group universities already support a range of clinical academic pathways, including academic clinical fellowships and university-led programmes that provide training opportunities, mentoring and protected research time.
Widening access
David Furness, managing director of the Shelford Group, a coalition of ten of the largest teaching and research NHS hospital trusts in England, welcomed the RG commitments.
Furness told University World News: “The Shelford Group is committed to working with the Russell Group and partners across health, research and higher education to strengthen and diversify the clinical academic workforce, remove barriers to participation, and reverse the decline in healthcare professionals pursuing these careers.”
The Council of Deans of Health is also supporting the new RG initiatives, with its chief executive Ed Hughes particularly welcoming the drive to widen access to careers in academia and research.
He said: “The education of nurses, midwives and allied health professionals needed to deliver government ambitions for health and social care is underpinned by the work of clinical academics bringing together their expertise in research and practice.
“Nurses, midwives and allied health professionals deliver for us all not only through their clinical practice but also in academia and research. Setting clinical academic career pathways up on a sustainable basis benefits everyone.”
Professor Sir Andrew Morris, president of the Academy of Medical Sciences, described the RG commitments as “extremely encouraging”.
He said the government should now match the ambition to grow numbers “by treating the clinical academic pipeline as essential national infrastructure” and use the forthcoming spending review to reverse the decline in numbers.
Learning from Germany
However, perhaps the UK could learn lessons from across the North Sea, from Germany and the work of Stiftung Charité and its pioneering structured clinician training in Germany.
Dr Inga Lödige, research funding manager of the Stiftung Charité foundation, told University World News: “Together with the Volkswagen Foundation and Charité – Universitätsmedizin Berlin, we developed a pilot programme in 2010 to address a major obstacle facing young physicians: the lack of protected time for research alongside their clinical responsibilities.
“Launched in 2011, the programme combined specialist medical training with dedicated research time (50%), much of which could be counted toward specialist qualification, and a structured scientific curriculum.
“The model has since been adopted widely across German university hospitals and has become an established approach to supporting clinical academic careers.
“In recent years, the German Research Foundation (DFG) has funded similar programmes nationwide, while the federal government has introduced funding programs for advanced clinician scientists to improve career prospects for physicians who have completed their specialist training.”
Address a fundamental challenge
The clinician scientist programmes are co-ordinated by the Berlin Institute of Health’s Biomedical Innovation Academy (BIA), where Dr Nathalie Huber, joint head of the clinician scientist office, told University World News: “Clinician Scientist Programmes have gained momentum across Germany because they address a fundamental challenge in academic medicine: how to enable research-active physicians to pursue clinical and research careers without having to choose between the two.
“By providing protected time for research, a structured competence-based curriculum and dedicated mentoring, these programmes create more attractive and sustainable career paths for early-career clinical academics.
“The Charité Clinician Scientist Programme has demonstrated over the past 15 years how this approach can successfully work in practice.
“With more than 400 alumni, currently 150 fellows and five tailored funding tracks for clinician scientists at different career stages – and nearly 50 departments and institutes involved, it has helped establish a model that serves as a reference point and ‘best practice model’ for academic career development across Germany – and beyond.”
Professor Il-Kang Na, director of the BIH Charité Clinician Scientist Programme, told University World News: “In recent years, Clinician Scientist Programmes have established, not only as an indispensable tool for personnel career development but also as a strategic tool for recruiting scientific talents in German university medicine.
“It is essential that clinician scientists form the essential bridge within the triad of competencies comprising patient care, teaching and research.
“By integrating these three complementary competencies, clinician scientists are uniquely positioned to drive scientific innovation, strengthen academic medicine and translate research advances into improved patient care.”
Nic Mitchell is a UK-based freelance journalist and PR consultant specialising in European and international higher education. He blogs at www.delacourcommunications.com.